REG - Smith & Nephew Plc - Director/PDMR Shareholding

Smith & NephewAnnouncement

03/11/2023 14:45

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20231103:nRSC3843Sa&default-theme=true

RNS Number : 3843S  Smith & Nephew Plc  03 November 2023

SMITH & NEPHEW PLC

 

3 November 2023

 

NOTIFICATION AND PUBLIC DISCLOSURE IN ACCORDANCE WITH THE REQUIREMENTS OF THE
EU MARKET ABUSE REGULATION OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL
RESPONSIBILITIES ("PDMR") AND PERSONS CLOSELY ASSOCIATED WITH THEM.

 

 Reason for the notification
 Initial notification /Amendment                              Initial notification
 Details of the issuer, emission allowance market participant, auction
 platform, auctioneer or auction monitor
 Name                                                         Smith & Nephew plc
 LEI                                                          213800ZTMDN8S67S1H61
 Details of the transaction(s): section to be repeated for (i) each type of
 instrument; (ii) each type of transaction; (iii) each date; and (iv) each
 place where transactions have been conducted
 Description of the financial instrument, type of instrument  Smith & Nephew plc ordinary shares of USD 0.20 each

 Identification code                                          ISIN: GB0009223206
 Nature of the transaction                                    Purchase of ordinary shares through the Company's Dividend Re-Investment Plan
                                                              following the 2023 interim dividend payment on 1 November 2023.
 Date of Transaction                                          2023 - 11 - 1
 Place of Transaction                                         London Stock Exchange (XLON)

 

 Name                                                            Director / PDMR  Price      Volume         Aggregated information

 (Position)
 Helen Barraclough                                               PDMR             £9.24546   378.63846      N/A Single Transaction

 (Group General Counsel and Company Secretary)
 Bradley Cannon                                                  PDMR             £9.24546    4.70426       N/A Single Transaction

 (President, Global Orthopaedics)
 Paul Connolly                                                   PDMR             £9.24546    95.16781      N/A Single Transaction

 (President, Global Operations)
 Phil Cowdy                                                      PDMR             £9.24546    2.52246       N/A Single Transaction

 (Chief Corporate Development & Corporate Affairs Officer)
 Mizanu Kebede                                                   PDMR             £9.24546    50.47884      N/A Single Transaction

 (Chief Quality & Regulatory Affairs Officer)
 Deepak Nath                                                     Director         £9.24546    1,275.12874   N/A Single Transaction

 (Chief Executive Officer)
 Alison Parkes                                                   PDMR             £9.24546    47.98799      N/A Single Transaction

 (Chief Compliance Officer)
 Scott Schaffner                                                 PDMR             £9.24546    722.89052     N/A Single Transaction

 (President, Sports Medicine)

 

 

 

 

Sarah Carne

Deputy Company Secretary

Smith & Nephew plc

 

Tel:  +44 (0)1923 477100

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  DSHFLFFSLALVIIV